Placebo (PLA)

DIETARY_SUPPLEMENT7 trials

Conditions

Dietary SupplementExerciseGlycogen Storage Disease Type IIGlycogen Storage Disease Type II Late OnsetGlycogen Storage Disease Type II, AdultKnee InjuriesKnee OsteoarthritisLysosomal Storage Diseases

Phase 2

Nutritional Therapy in Late-onset Pompe Disease

NCT06130228

McMaster UniversityGlycogen Storage Disease Type II, Glycogen Storage Disease Type II, Adult, Glycogen Storage Disease Type II Late Onset +5

Start: 2024-04-01End: 2025-04-01Target: 28Updated: 2023-11-14

Phase 3

A Study of Duloxetine in Patients With Osteoarthritis Knee Pain

CompletedNCT00945945

Eli Lilly and CompanyOsteoarthritis Knee Pain

Start: 2009-07-31End: 2010-05-31Updated: 2011-03-08

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

CompletedNCT01112644

Mundipharma Research GmbH & Co KGModerate to Severe Idiopathic RLS With Daytime Symptoms

Start: 2010-04-30End: 2011-06-30Updated: 2018-10-23

Unknown Phase

The Effect of New Zealand Blackcurrant (NZBC) Supplementation on Recovery Following Strenuous Exercise

CompletedNCT05010057

University of SurreyMuscle Damage

Start: 2016-06-10End: 2018-09-01Updated: 2021-08-18

Evaluation of the Effect of a Food Supplement Based on Hydrolyzed Collagen on Joint Function.

NCT05917925

Francisco Javier Martínez NogueraKnee Injuries, Knee Osteoarthritis, Pain, Acute +1

Start: 2023-04-01End: 2024-06-30Target: 80Updated: 2023-07-06

Effect of a New Formulation of Vitamin B12 on Physical and Mental

RecruitingNCT06639789

Francisco Javier Martínez NogueraPerformance Enhancing Product Use

Start: 2024-07-01End: 2024-12-31Target: 18Updated: 2024-10-15

Coffee Increases Physical and Cognitive Performance Both in Men and Women

CompletedNCT07474753

Northumbria UniversityDietary Supplement, Exercise

Start: 2020-12-04End: 2021-03-20Updated: 2026-03-16

Related Papers

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension.

2016-08-017 citations

Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.